Cigna: Best insurance for Wegovy and other weight loss drugs ValuePenguin rating3.5/5ValuePenguin rates companies based on cost, coverage, service and unique features
Start your intake Why Gradual Dose Reduction Matters for GLP-1 Therapy Abruptly stopping any GLP-1 receptor agonistincluding Wegovycan produce a rebound effect where appetite hormones rapidly normalize and hunger signals intensify
It is recommended to optimise glycaemic control via dose adjustment based on fasting plasma glucose (see section 5.1 please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information )
We want to look at fasting insulin, hemoglobin A1C, A lipid profile, and uh, H-S-C-R-P, which is highly sensitive
Others, like tirzepatide, are dual agonists, targeting both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors
Best for Menopause and Perimenopause Every program above was scored on price, breadth, and clinical rigor
